GlassScriptPhysician profile
Jeffrey S Brown
NPI 1437152782
$27,440.96
in general payments reported to CMS, 2019-2025
39 companies · $990 in 2025
The $990 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $1,693 · 2021: $708 · 2022: $1,151 · 2023: $748 · 2024: $1,397 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,113 · Education: $22.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,113.36 |
| Education | $22.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21,455.48 | 2019-2025 | Synthroid, Botox |
| Ibsa Pharma INC. | $1,697.24 | 2019-2024 | Tirosint, Licart, Tirosint |
| Amneal Pharmaceuticals LLC | $840.54 | 2019-2025 | Unithroid |
| Esperion Therapeutics, INC. | $386.38 | 2020-2025 | Nexletol, Nexlizet |
| Lilly USA, LLC | $324.37 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $322.73 | 2019-2022 | |
| Dexcom, INC. | $261.34 | 2022-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $180.17 | 2019-2025 | Tepezza, Evenity |
| Bioventus LLC | $161.34 | 2022 | |
| Abbott Laboratories | $157.61 | 2021-2025 | Freestyle Libre 3 |
| Endo Pharmaceuticals INC. | $153.55 | 2020-2023 | Nascobal |
| Xeris Pharmaceuticals, INC. | $148.60 | 2022-2024 | Recorlev, Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.72 | 2019-2025 | Jardiance, Tradjenta |
| Radius Health, INC. | $126.42 | 2019-2024 | Tymlos |
| Mannkind Corporation | $118.94 | 2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.